no abstract available

Rangraze, I., Patoulias, D., Karakasis, P., El-Tanani, M., Rizzo, M. (2024). Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era?. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 17(10), 853-856 [10.1080/17512433.2024.2408753].

Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era?

Rizzo, Manfredi
2024-10-04

Abstract

no abstract available
4-ott-2024
Settore MEDS-08/A - Endocrinologia
Rangraze, I., Patoulias, D., Karakasis, P., El-Tanani, M., Rizzo, M. (2024). Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era?. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 17(10), 853-856 [10.1080/17512433.2024.2408753].
File in questo prodotto:
File Dimensione Formato  
Tirzepatide a novel dual glucose-dependent insulinotropic polypeptide glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic t.pdf

Solo gestori archvio

Tipologia: Pre-print
Dimensione 2.18 MB
Formato Adobe PDF
2.18 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/670489
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact